Arkolith/Insider Trading/CGEM/Form 4

Ebeling Thomas

DirectorCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed May 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 23, 2024Grant(A)84K$4.30$362K152K
May 23, 2024Grant(A)16K$12.73$210K168K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 23, 2024Option exercise(M)84K—$00
May 23, 2024Option exercise(M)16K—$00

Transaction Codes

A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-063948) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML